Navigation Links
Watson Reaches Settlement with Mallinckrodt Over Exalgo(R)
Date:1/26/2012

PARSIPPANY, N.J., Jan. 26, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that its subsidiary, Watson Laboratories, Inc.- Florida has reached a settlement with Mallinckrodt Inc. on outstanding patent litigation related to Watson's generic versions of Mallinckrodt's Exalgo® (Hydromorphone Hydrochloride Extended-Release ) tablets.  Mallinckrodt filed its lawsuit on December 10, 2010 in the United States District Court for the District of New Jersey following Watson's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its product in the 8 mg, 12 mg, and 16 mg dosage strengths.
Under terms of the settlement agreement, Mallinckrodt has granted Watson a royalty-free license to U.S. patents relating to Exalgo®.  Watson will have the right to launch its bioequivalent products on November 15, 2013.  Other details of the settlement were not disclosed.

Based on available information, Watson believes it may be a "first applicant" to file an ANDA for the generic version of Exalgo® and, should its ANDA be approved, may be entitled to 180 days of generic market exclusivity.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Forward-Looking Statement Statements contained in this press release that refer to non-h
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: ... participate in the Deutsche Bank Health Care Conference to ... Hotel.  Mr. Adrian Adams , Chief ... overview of the Company and its product pipeline at ... (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The ...
(Date:5/24/2013)... May 24, 2013 The potential ... systemic delivery of therapeutic agents has been receiving undeniable ... delivery showing significant promise. The crucial formulation considerations for ... device play a major role in the efficiency of ... the development of new formulation techniques and devices in ...
(Date:5/23/2013)...  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ) ... Life Science Firm of the Year by the Tech Council ... at the TCM,s 25 th Annual Tech Awards Celebration ... Awards Celebration recognizes the leaders and innovators in the technology ... and the surrounding regions. "We are deeply ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2
... , June 1 /PRNewswire-Asia/ -- www.medicalequipmentpro.com , one of,the ... coming Father,s Day . The promotion involves free shipping on,orders above ... home health care such as the wrist blood pressure monitor. , ... High blood ...
... HELSINKI , June 1, 2010 MediSapiens, world,s first,software company ... 1 million ( EUR 0.8 million ) seed round,investment from Veraventure, ... , , ... on scientific research at the VTT Technical Research,Centre of Finland ...
Cached Medicine Technology:Medicalequipmentpro.com Offers Father's Day Discounts to Ensure this Father's Day is a Healthy One 2Medicalequipmentpro.com Offers Father's Day Discounts to Ensure this Father's Day is a Healthy One 3MediSapiens Gets $ 1 Million for World's First Personalized Cancer Medicine Software 2MediSapiens Gets $ 1 Million for World's First Personalized Cancer Medicine Software 3MediSapiens Gets $ 1 Million for World's First Personalized Cancer Medicine Software 4
(Date:5/25/2013)... Los Angeles, CA (PRWEB) May 25, 2013 ... will grow at an average annual rate of 28.7% ... growth of 17.9% in 2013. From 2002 and 2008, no ... analyst Kevin Culbert, causing relatively modest growth during that period. ... (FDA) has approved six new products. This factor contributed to ...
(Date:5/25/2013)... Texas (PRWEB) May 25, 2013 ... stressful than finals week. Increasingly, they are turning ... stay awake and study. For more on this, ... a drug treatment facility, warns that students who ... finals” are at risk for developing a physical ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 Ayurveda ... Ayurveda means "knowledge or wisdom of life". While a medical ... and the transformation of consciousness. Its fundamental philosophy is that ... with our environment. It believes that in order to re-establish ... of harmony and then adopt a life style which brings ...
(Date:5/25/2013)... Flagstaff, Arizona (PRWEB) May 25, 2013 The ... Rehabilitation Center, their parents, and the B2B staff all came ... While everyone enjoyed an array of Indian Cuisine, the residents ... the company, for helping them on their road to recovery, ... started the Drug and Alcohol center in 2010 after realizing ...
(Date:5/25/2013)... CA (PRWEB) May 25, 2013 ... news of a judge's overturning of a jury's award ... in the first trial* in the country over allegations ... according to court files. , The judge in the ... evidence to show his cancer was caused by the ...
Breaking Medicine News(10 mins):Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2Health News:Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes 2Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 2Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 3Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 4
... say , TUESDAY, June 30 (HealthDay News) -- American physicians ... received injections of his own heart stem cells to repair ... of 16 people who will undergo the procedure as part ... Heart Institute in Los Angeles. Another eight people will act ...
... feel obliged to bring unresponsive patient to hospital, study finds ... a heart attack that occurs outside of a hospital are ... a hospital anyway because a variety of factors keep them ... , In the United States, paramedics treat almost 300,000 people ...
... better than standard criteria, study finds , TUESDAY, June ... such as inflammation-linked C-reactive protein (CRP), add little ... as smoking, obesity, high cholesterol and physical activity, two ... been touted as a better way of assessing heart ...
... metabolic syndrome may play a role in the risk ... in Cancer Epidemiology, Biomarkers & Prevention , a ... The metabolic syndrome, or insulin resistance syndrome, consists ... blood glucose levels, impaired glucose tolerance, abnormal lipid levels ...
... used improperly , TUESDAY, June 30 (HealthDay News) -- ... maximum dose for Tylenol and other pain medications should ... advisers recommended lowering the maximum dose of over-the-counter acetaminophen ... medications. , Part of the problem, according to an ...
... postmenopausal women , TUESDAY, June 30 (HealthDay News) ... other components of metabolic syndrome might be at increased ... , Metabolic syndrome, also known as insulin resistance syndrome, ... obesity, high blood glucose levels, impaired glucose tolerance, abnormal ...
Cached Medicine News:Health News:U.S. Doctors Treat Heart Attack With Man's Own Stem Cells 2Health News:Even After Death, Heart Attack Treatment May Not End 2Health News:Even After Death, Heart Attack Treatment May Not End 3Health News:Even After Death, Heart Attack Treatment May Not End 4Health News:Newer Blood Tests May Not Improve Heart Risk Assessment 2Health News:Newer Blood Tests May Not Improve Heart Risk Assessment 3Health News:Metabolic factors may play a role in risk for breast cancer 2Health News:Metabolic factors may play a role in risk for breast cancer 3Health News:FDA Advisers Recommend Smaller Doses of Acetaminophen 2Health News:Metabolic Syndrome May Make Breast Cancer More Likely 2
... The PulseOx 5500TM is the worlds ... oxygen saturation and heart rate to ... PulseOx 5500TM uses SPO Medicals patented ... which is more usable for many ...
The Onyx® 9500 worlds first self-contained digital fingertip pulse oximeter incorporates the electronics and the sensor into one unit....
... Sleep Printing Pulse Oximeter ... to address the growing ... that can easily be ... screening for qualifying or ...
The FetalSAT™ System with DualSens Sensor displays continuous, real-time fetal pulse oximetry (FSpO2) and fetal pulse rate (FPR) values in one compact monitor....
Medicine Products: